Clinical trial · Observational
Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients
NCT02190864CI-TRIAL-00020057unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Our long-term goal is to integrate non-small cell lung cancer patient treatment preferences into clinical treatment planning.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Age | — | UNRESOLVED | — |
| Comorbid Conditions | — | UNRESOLVED | — |
| FACT-TOI Scores | — | UNRESOLVED | — |
| Gender | — | UNRESOLVED | — |
| Particularly Rural/Urban Residence | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Patient-defined "treatment success"
- timeFrame
- Baseline
- description
- In advanced stage NSCLC patients does patient-defined "treatment success" differ when both survival and patient preferences of adverse events are accounted for, compared to when success is measured solely by survival? And does it also differ based on individual patient characteristics?
- measure
- Patients' will to experience adverse events
- timeFrame
- Baseline
- description
- Will the serious adverse events that an advanced stage NSCLC patient is willing to experience as part of his/her treatment differ after a real-life treatment experience, compared to before treatment?
Secondary outcomes (1)
- measure
- Summary score derived from patient preferences of adverse events
- timeFrame
- Up to three months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * Willing and able to provide consent * Greater than or equal to 19 years of age * Diagnosed with stage IV non-small cell lung cancer (NSCLC) * Able to understand spoken English * Eligible to undergo chemotherapy for stage IV NSCLC, to include, but not limited to, those who: 1. have not yet started chemo 2. are currently undergoing chemo for stage IV NSCLC 3. have completed first line stage IV NSCLC chemo or progressed to maintenance for stage IV NSCLC within the last 30 days 4. elect to have chemo elsewhere -- not at one of the study sites 5. decline chemo Exclusion Criteria: * Age \<19 years * Not willing and/or able to provide consent * Not able to understand spoken English * Not eligible to undergo chemotherapy for stage IV NSCLC
References
Publications (0)
Data not yet available
No reference posted for this study.